“You’re not important enough to talk to me.”
Richard Dalton said it before I had even finished introducing myself, cutting across the private dining room of a Boston hotel with the casual contempt of a man who had spent decades assuming everyone’s value could be measured by a title printed beneath their name. My daughter, Sophie, froze beside her fiancé, Andrew Dalton, while Andrew’s mother lowered her wineglass and stared at her husband as though she could not believe he had chosen their children’s engagement dinner to humiliate the bride’s mother.
My name is Katherine Monroe, I was fifty-two, and Richard knew only what Sophie had deliberately told his family: that I worked “in investments” and preferred keeping my professional life separate from family events. He apparently interpreted that as meaning I managed someone’s retirement accounts, because after dismissing me he immediately turned toward a venture-capital executive across the table and resumed discussing Dalton Medical Technologies as if I had ceased to exist.
“Dad,” Andrew said sharply, “that was completely unnecessary.”
Richard waved him off. “We’re here with people who actually understand what is happening in this industry, Andrew, and I have spent eighteen months getting this acquisition across the finish line.”
That sentence almost made me smile.
Dalton Medical Technologies, the medical-device company Richard had run for seventeen years, was indeed negotiating an acquisition valued at approximately $740 million. What Richard did not know was that the buyer, Northstar Health Partners, was controlled by Monroe Capital Group, the private investment firm I had founded twenty-three years earlier after leaving a major Boston bank.
He also did not know that I chaired Northstar’s investment committee.
For six months, Richard had been negotiating with my managing directors, attorneys, and operating partners while I remained deliberately removed from day-to-day discussions because Sophie had begun dating Andrew long before Dalton became an acquisition target. I wanted absolutely no suggestion that my daughter’s relationship had influenced a transaction involving hundreds of employees and millions of dollars.
Richard finally looked back toward me. “No offense, Katherine, but deals like this are complicated.”
“None taken,” I said.
Then I picked up my phone.
Sophie whispered, “Mom?”
I called David Chen, Northstar’s managing director overseeing the transaction. He answered immediately.
“David, it’s Katherine. Stop the Dalton acquisition process tonight and notify legal that I want the transaction terminated under the withdrawal provisions in the letter of intent. No further negotiations until the investment committee reviews it.”
Richard’s head snapped toward me.
The room went completely silent.
David paused. “Understood. I’ll contact counsel now.”
I ended the call.
Richard stared at me.
“Who exactly are you?”
I placed my phone beside my plate.
“The person whose company was about to buy yours.”



